Related Experiment Video
Updated: Aug 25, 2026
10:32
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
[Recent advances in retinopathy of prematurity]
1Department of Ophthalmology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. huodongm@yahoo.com.cn
Insights
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness globally. This condition, characterized by abnormal blood vessel growth in the retina, requires understanding its causes, detection, and management.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatric Medicine
Context:
- Retinopathy of prematurity (ROP) is a significant global health concern, particularly impacting premature infants.
- It represents a major cause of preventable blindness in children worldwide.
- Understanding ROP is crucial for early intervention and improving visual outcomes.
Purpose:
- To provide a comprehensive overview of retinopathy of prematurity.
- To detail the risk factors, underlying causes, and diagnostic methods for ROP.
- To discuss current treatment strategies and emerging advancements in ROP management.
Summary:
- Retinopathy of prematurity (ROP) is a complex vasoproliferative disorder affecting the retina.
- Key aspects covered include etiology, identification of risk factors, diagnostic approaches, and therapeutic interventions.
- Recent developments and future directions in ROP research and clinical practice are highlighted.
Impact:
- Enhances understanding of ROP for healthcare professionals.
- Aims to reduce the incidence of blindness caused by ROP in children.
- Facilitates informed clinical decision-making and improved patient care for ROP.
Abstract:
Retinopathy of prematurity (ROP) is a vasoproliferative retinopathy. Worldwide, ROP is a major cause of blindness in children. This chapter describes its risk factors, etiology, diagnosis, treatment and recent advances.
